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Abstract 
 It is estimated that 7,000 total hip arthroplasty (THA) revision procedures due to infection 
will occur in the year 2015, with this number expected to increase substantially by 2030 (Kurtz et al., 
2007). Due to a lack of surgeon accessibility to the necessary equipment needed to perform these 
procedures, it is becoming increasingly essential to develop devices that increase surgeon 
accessibility and usability of revision materials. Therefore, the goal for our project was to design a 
readily-available, cost-effective, universal, and disposable kit, comprised of a set of femoral molds, to 
facilitate the treatment of THAs by a two-stage revision hip arthroplasty. Our method utilizes a 
Konica Minolta Range 7 3-D scanner and 3-D printing technologies to manufacture a set of silicone 
molds, used to create the temporary antibiotic-loaded cement spacers used in this procedure. These 
molds are considered universal as they can be tailored to the primary hip prostheses and surgical 
broaches that the orthopedic surgeon might regularly stock in the hospital. Our product addresses 
the main goal of increasing accessibility by providing hospitals with a full set of disposable silicone 
molds, which can be stored on shelf and used as needed in the operating room. Our results conclude 
that this method can be used to produce a temporary spacer that is cost-effective, non-cytotoxic, 
and is dimensionally comparable to the originally scanned implant, thus ensuring an accurate and 
reliable press-fit component.  
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Chapter 1: Introduction 
In 2010, 332,000 total hip arthroplasties (THA) were performed in the United States, alone 
(CDC, 2010). Further, due to the United States’ aging population and increasing life expectancy, the 
annual incidence of THAs is expected to increase (Cheng, 2012). As the number of THAs continues 
to increase, so too will the number of hip revision arthroplasties. The three most common reasons 
for implant failure after THA surgeries are instability/dislocation (22.5%), mechanical loosening 
(19.7%), and infection (14.8%) (Boettner et al., 2011). The incidence of revision surgeries for 
infected THAs alone is widely debated among researchers but could affect well over 7,000 
individuals in the United States (Kurtz et al. 2009; Boettner et al., 2011). 
Depending on the time taken to detect the infection and its severity, there are a variety of 
viable treatment options. If the infection is detected after three weeks post-onset, an orthopedic 
surgeon may choose to perform a two-stage revision arthroplasty to manage the septic failure of 
THAs (Ellenrieder et al., 2011); this procedure is considered the gold standard for treating infected 
hip implants. During a two-stage revision arthroplasty, the surgeon removes the infected hip 
implant; upon removal, a broach is inserted into the femoral canal to create space in which the 
temporary component will be inserted. The temporary component is molded with antibiotic-loaded 
bone cement and inserted in place of the primary hip prosthesis, which allows the infection to be 
treated prior to the surgeon performing the second stage of the two-stage revision arthroplasty 
(Senthi et al., 2011).  
The DePuy Prostalac Hip System (Prostalac, 2010), is perhaps the most widely utilized 
system for two-stage hip revision arthroplasties. Previous studies deem this system highly efficacious 
in two-stage revision hip arthroplasties; however, there remains substantial room for improvement. 
Perhaps of the greatest concern lies in the fact that there is only a single kit available to orthopedic 
surgeons in New England, which is delivered to New England's regional hospitals upon request by a 
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medical device sales representative (J. Wixted, personal communication, Sept. 17, 2014). 
 Furthermore, although the DePuy Prostalac Hip System has been deemed effective, further 
limitations remain regarding brand specificity, price, disposability, and accessibility. Based on the fact 
that the Prostalac Hip System was manufactured by DePuy Orthopaedics Inc., a Johnson & Johnson 
company, its components were designed such that DePuy products are most compatible with the 
system's equipment. Because the kit is reusable following a postoperative sterilization process, the 
financial model is such that physicians do not have to pay money to rent the kit for use; instead, they 
are required to purchase the components within the kit that are not reusable, which include a 
stabilizing hip stem, acetabular cup, and bone cement. However, because this is the only kit available 
to New England physicians, DePuy is able to charge exorbitant prices for these components, even if 
the cost of these components separate from the Prostalac Hip System are available at a greatly 
reduced price. Additionally, as previously stated, the Prostalac Hip System is non-disposable; 
therefore, the kit’s components must be sterilized post-operation before it can be used again on 
another patient. If sterilization guidelines were not strictly followed, microbial contamination could 
result in person-to-person disease transmission via contaminated devices (Rutala & Weber, 2004). 
 Lastly, since there is only one Prostalac Hip System in the New England region, if two 
surgeons were to need the kit on the same day, one of them would need to tell their patient that they 
must wait up to several days in order to have surgery. This also poses a concern since many 
infections are detected when a surgeon is treating a patient for what he/she thinks is a mechanical 
failure. However, after opening the patient up, in many cases the patient’s pain was actually a result 
of an infection at the site of the implant. Unfortunately, surgeons do not have the necessary 
equipment on shelf to perform a two-stage arthroplasty at the onsite of detection. Therefore, the 
surgeon must close the patient up and wait until the Prostalac kit is ordered and perform the 
procedure at a later date. The lack of accessibility that surgeons have to this device therefore could 
14 
 
lead to additional co-morbidities associated with the infection, ultimately leading to patient 
dissatisfaction and discomfort.  
The goal of this project, therefore, is to design a medical kit comprised of components to 
perform a revision hip arthroplasty that accommodates the wide variety of hip implant brands and 
models on the market, and is cost-effective, disposable, and accessible. For the equipment to be 
disposable and accessible, the materials chosen for the design coupled with the manufacturing of the 
equipment must be more inexpensive than the current system. Additionally, the manufacturability 
and sterilizability of the equipment will be considered to ensure reproducibility and patient safety, 
respectively. Further, the components must be sized such that they are capable of accommodating 
for the variety of prosthesis brands in stock.  
To achieve such, we propose a medical device that will simplify the process of performing a 
two-stage, hip revision arthroplasty. We suggest that by utilizing 3-D scanning technologies, various 
disposable molds, which may form the temporary antibiotic-loaded cement spacers, can be produced 
to allow surgeons to use surgical broaches and hip stems that are already stocked in the hospital, 
regardless of what brand or model of hip implant they may use. This will allow surgeons to perform 
this procedure at a reduced cost compared to existing techniques, while furthermore, increasing their 
accessibility to the tools necessary to perform two-stage revision hip arthroplasties. 
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Chapter 2: Literature Review 
2.1 Clinical Need for Revision Hip Replacements   
In 2010, 332,000 total hip arthroplasties (THA) were performed in the United States, alone 
(CDC, 2010). However, due to the United States’ aging population and increasing life expectancy, 
the annual incidence of THAs is expected to increase (Cheng, C. 2012). On account of the aging 
population and its increasing life expectancy, Kurtz et al. (2009) projected that the number of THAs 
in the United States would exceed 800,000 by 2030. 
Several risk factors, which may predispose a patient to a primary THA, include osteoarthritis, 
rheumatoid arthritis, osteonecrosis, injury, fracture, and bone tumors. These conditions can lead to 
the breakdown of the hip joint, thus leading to decreased mobility and increased joint pain (NIAMS, 
2013). To increase mobility and alleviate joint pain, patients rely heavily on hip replacement 
surgeries. Figure 1 depicts a typical hip replacement surgery whereby the surgeon first removes the 
compromised or diseased tissue and cartilage from the hip joint and replaces the head of the femur 
and the acetabulum with artificial components to promote natural articulation of the hip.  
 
Figure 1: Hip Replacement; (Anterior Femur, 2000; Takano, Junji 2014. Retrieved from, 
http://www.pyroenergen.com/articles12/hip-joint-pain.htm) 
Because human femora vary dimensionally, it is difficult to achieve a proper fit utilizing 
current implants, and they may therefore be subject to early revision. While the primary arthroplasty 
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has proven to be highly successful, many of these replacements will require premature revision 
surgeries as a result of both aseptic and septic failure (Boettner et al., 2011). Nearly 6.5% of all 
primary THAs will require revision surgery within five years of the procedure, which nearly doubles 
after ten years (Labek et al., 2011).  
      Provided the increase in the number of THAs performed annually in the United States, the 
number of complications necessitating revision surgery also increases (Aggarwal, Rasouli & Parvizi, 
2013). The three most common reasons for implant failure after THA are instability or dislocation 
(22.5%), mechanical loosening (19.7%), and infection (14.8%) (Boettner et al., 2011). Unfortunately, 
with the increased need for hip replacement surgeries, researchers estimate that by 2030, the rate of 
revision THAs will exceed 90,000 annual procedures (Kurtz et al., 2009). This indicates that in the 
near future, over 13,000 revision procedures may be performed to counteract the presence of septic, 
infected hip implants, thereby necessitating the availability of viable treatment options. 
2.2 Septic Hip Revision Surgery 
2.2.1 Causes and Risk Factors of Hip Implant Failure Due to Infection 
 Kurtz et al. (2009) report that at the time of the study, it could be projected that by 2010, 
over 45,000 revision THAs would have been performed in the United States. In accordance with 
Kurtz et al. (2009) and Boettner et al. (2011), it is estimated that nearly 7,000 revision hip 
arthroplasties are performed annually as a result of implant infection. Deep prosthetic infections 
following THA are often difficult to treat because they may occur at the superficial incision or deep 
around the joint prosthesis (AAOS, 2011). Even a minute quantity of bacteria can create a 
permanent device-associated biofilm, which would prevent the body’s immune system from fighting 
the infection at the implant site (Zimmerli, 2006). As a result of such, a patient could experience 
many adverse effects related to implant infection, which include serious morbidity, indicating severe 
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pain, loss of joint function, and implant failure, and sometimes even mortality (Berendt & McLardy-
Smith, 1999).  
2.2.2 Treatment Methods 
     Upon detection of an infected implant, it is vital to intervene. If an infected implant is left 
untreated the bacteria can proliferate and become a systemic problem in the body. When bacteria 
attach to an implant, the immune system can no longer fight it, which is why the implant must be 
removed (Cluett, 2014). At the tissue-implant interface, the body’s immune response is inefficient at 
clearing the infection due to the biological environment created at the implant surface. Depending 
on the time taken to detect the infection and its severity, there are a variety of viable treatment 
options available, including debridement with retention of the implant, one-stage arthroplasty, and 
two-stage arthroplasty. 
Debridement with Retention of the Implant      
 Debridement with retention of the implant is a surgical procedure for the treatment of 
infected THAs when the infection has been detected within three weeks of onset (Zimmerli, 2006). 
As a result, the surgeon will remove the infected tissue surrounding the implant while retaining the 
prosthesis in the patient’s body. The patient is subsequently administered oral antibiotics to aid in 
treating the infection. Infections that are detected early are more easily treated due to the fact that 
the bacteria at the implant site have not yet penetrated deep within the tissue, nor have they formed 
a biofilm layer, whereby the infection would worsen. Although this method is simple and affordable, 
its success rates are inconsistent depending on how efficiently the surgeon cleans the infected areas 
(Tintle et al., 2009). 
One-Stage Revision Arthroplasty      
 If a patient presents with an infection existing for more than three weeks, but the 
surrounding soft tissue is still intact or only slightly compromised, a one-stage revision surgery may 
be the most viable treatment option. This procedure entails the removal of the prosthesis and the 
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implantation of the same one in the same surgical procedure (Zimmerli, 2006). An advantage of 
one-stage arthroplasties is that the patient is exposed to a lower perioperative risk. Additionally, one-
stage revision arthroplasties incur less of a financial burden, in that resources are preserved and a 
new prosthesis is not necessary. However, this treatment method is not frequently utilized because 
there is often an associated fear of recurring infections due to re-implantation (Senthi et al., 2011). 
Despite this fear, the success rate of this procedure has been reported to range from as 81.9%-100% 
(Zimmerli, 2006; Aggarwal, Rosouli & Parvizi, 2013).  
Two-Stage Revision Arthroplasty 
 If the infection is detected after three weeks post-onset, a surgeon may choose to perform a 
two-stage revision arthroplasty to treat the infection (Ellenrieder et al., 2011). This procedure is 
preferred by surgeons among the various treatment methods and is considered the gold standard for 
the surgical management of infected THAs (Senthi et al., 2011) since surgeons have utilized it for 
more than four decades (Aggarwal, Rasouli & Parivizi, 2013). 
Unlike the one-stage arthroplasty whereby the primary implant is removed and a new 
implant is inserted into the body in the same procedure, a two-stage arthroplasty requires that the 
primary implant is removed and an antibiotic-loaded cement spacer is inserted into the femoral canal 
in the first stage of the procedure. If the implant were to be removed without reinserting a 
temporary spacer, the presence of the opposing muscular tensions would act to pull the femur 
superiorly to its normal position in the body. The spacer simply acts to maintain limb position and 
length; the antibiotic loaded cement mantle surrounding the temporary spacer acts primarily to 
ensure the temporary component does not introduce new infection to the implant site, which would 
further compound the problem. The patient will be administered intravenous antibiotics once the 
primary implant is removed to clear the primary infection. A second procedure is performed at a 
later date, during which the spacer is removed and a new prosthesis is implanted. 
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The first stage of the procedure entails removing all foreign material. A surgical instrument, 
referred to as a broach, illustrated in Figure 2a, is used to debride the infected tissue and clear the 
medullary canal of any residual material from the primary implant, while also creating space for the 
temporary component to be inserted (Aggarwal, Rasouli & Parivizi, 2013). The temporary 
component, referred to as a spacer, seen in Figure 2d, is formed by injecting antibiotic-loaded bone 
cement into a mold and allowing it to cure (Figure 2b & c) before being implanted into the femoral 
canal. On average, the cement spacer will remain in the body for 4-8 weeks; during this time, the 
patient also receives intravenous and oral antibiotics to treat the residual infection. As described 
earlier, due to the high variability of human femora and the importance of prosthesis fit to 
effectively retain the component, it is vital that both the broaches and the temporary components 
are available in a variety of sizes to best accommodate the differing dimensions (Noble et al., 1988).  
 
Figure 2: Broach (a), Mold (b), Stem insertion into mold (c), Temporary antibiotic loaded cement spacer (d);  
(Prostalac Hip System – Surgical Technique, 2010. Retrieved from, http://gsortho.org/) 
In the second stage of a two-stage arthroplasty, the cement spacer is removed and a new 
prosthesis is inserted into the femoral canal (Aggarwal, Rasouli & Parivizi, 2013). Although a two-
stage arthroplasty is considered the gold standard for treating infected THAs, discrepancies remain 
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regarding the correct timing for administering antibiotics, the appropriate use of the articulating 
spacers, and the correct time period prior to re-implantation (Senthi, Munro & Pitto, 2011; 
Aggarwal, Rosouli & Parivizi, 2013). Despite this, two-stage revision arthroplasties generally have a 
success rate that exceeds 90% (Zimmerli, 2006; Senthi, Munro & Pitto, 2011). 
2.2.3 Current Products 
There are several products currently on the market for the treatment of infected THAs. The 
two main categories of the current revision products are articulating and static temporary spacers. 
An articulating spacer is comprised of a separate head and stem component, while a static spacer is a 
single module that incorporates both the head and stem into the same component. Studies have 
shown that the use of articulating spacers in the first stage of a two-stage arthroplasty is more suited 
for maintaining soft tissue tension, meaning that the tissues surrounding the spacer are more able to 
maintain their structural and physiologic integrity (Bloomfield, M. R., Klika, A. K., & Barsoum, W. 
K., 2010). Articulating spacers have also been shown to allow an increase in the joint's range of 
motion when compared with static spacers, which allows for faster recovery times following the re-
implantation of the new prosthesis. Depending on the patient’s needs however, a static spacer may 
be preferred; due to the fewer number of components needed with static spacers, the increased ease-
of-use and decreased time spent in surgery may be preferred (Chalmers, 2011). 
TECRES Temporary Spacer 
There are a variety of static revision systems available for surgeons to use in the treatment of 
infected hip implants. The TECRES Temporary Spacer, seen in Figure 3, is a static spacer, created 
for partial load bearing by the patient following implantation. The spacer is composed of a stainless 
steel core stem coated in PMMA bone cement that has been loaded with gentamicin or vancomycin. 
This system has three varying head sizes and two stem lengths in an effort to accommodate multiple 
existing, primary hip stem sizes. Like the other spacers discussed, the TECRES Temporary Spacer 
also maintains joint space and mobilization of the patient after surgery and has an effective release of 
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antibiotics to fight infection. However, because it is a static spacer, it only allows for deambulated, 
partial weight bearing because the spacer itself is not approved for the mechanical stresses of full 
load-bearing activities. This kit also does not provide specific broaches to match the dimensions of 
the spacer given. This could cause difficulties during surgery because if the stem does not match the 
broach size then the hip implant may fail as a result of improper fit, or not being long enough to 
attach to healthy, uninfected bone. The limited number of sizes available for the spacers also 
prompts concern since it is important that the spacer be an appropriate size for the patient's 
anatomical dimensions to ensure proper implant fit (TECRES, 2007). 
 
Figure 3: TECRES Temporary Spacer is a good option due to the stainless steel core being pre-coated in PMMA bone cement; 
(TECRES, 2007. Retrieved from, http://www.tecres.it/) 
InterSpace Hip  
 Like the TECRES Temporary Spacer, the InterSpace Hip, illustrated in Figure 4, is a partial 
load bearing, static spacer. It too, is composed of a stainless steel reinforcing core and coated in 
PMMA bone cement that has been loaded with gentamicin or vancomycin. Unlike the TECRES 
spacer though, the InterSpace Hip has six different stem sizes, which allow for greater 
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customizability and fit within a wider range of patient demographics. One additional advantage is 
that the InterSpace Hip is designed to have an increased surface area, and therefore a greater 
biological interface, allowing for greater antimicrobial activity than other treatment options 
(InterSpace Hip Operative Technique, 2011). 
 
Figure 4: InterSpace Hip is very similar to the TECRES Temporary Spacer but offers a greater surface area for implant to tissue 
interaction; (InterSpace Hip Operative Technique, 2011. Retrieved from, http://www.exac.com/) 
Biomet StageOne Select 
 Another product currently being used in two-stage revision arthroplasties is the Biomet 
StageOne Select, seen in Figure 5, which uses multiple components to create an articulating 
temporary implant. It consists of four different stem sizes that coincide with the variety of broaches 
that Biomet already produces. These broaches are not specific to the revision procedure, and they 
are not provided with the revision kit. The absence of the broaches could add difficulties when 
aiming to ensure that all components are available at the time of surgery. The kit does, however, 
provide a variety of medical grade silicone molds already equipped with reinforced stainless steel 
stems. PMMA bone cement is injected into the medical grade silicone mold and allowed to cure 
before the silicone is removed, and the cured spacer is implanted into the body. Upon injection of 
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the bone cement into the mold, the surgeon must take profound care to ensure that air pockets or 
other imperfections are not introduced into the spacer as this could severely compromise the 
structural integrity of the spacer. Unfortunately, the StageOne Select is also brand-specific, in that 
the molds are only fit to accommodate specific Biomet reinforcing, revision stems, and therefore, 
this kit may not be useful to a surgeon using another company's products. Despite these 
shortcomings though, the Biomet StageOne Select system is a single-use device and is disposed of 
following each revision procedure, thereby reducing the risk of cross contamination and decreasing 
operating costs of using the device (StageOne Select – Hip Cement Spacer Molds, 2013). 
 
Figure 5: Biomet StageOne Select offers a unique mold system which PMMA is injected to perfectly fit the stem; (StageOne 
Select – Hip Cement Spacer Molds, 2013. Retrieved from, http://www.biomet.fi/) 
DePuy Prostalac Hip System 
 The DePuy Prostalac Hip System (Figure 6) is a surgical kit used for creating an articulating 
hip spacer and is considered the gold standard for two-stage revision arthroplasties. This system 
consists of both broaches and molds, which are used to clear and prepare the femoral canal and to 
form the antibiotic-loaded bone cement spacer, respectively. The Prostalac Hip System contains a 
set of broaches, constructed from a medical grade metallic alloy, that are available in four sizes to 
ensure a more appropriate fit for the temporary component. This size is determined based on the 
size of the patient's previous hip implant. Molds are also provided in the kit and are made of a 
reusable, sterilizable, metal alloy. Inserts are additionally provided for the mold to allow for the 
temporary implant to be formed into four different sizes so the spacer created fits the dimensions 
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broached into the femoral canal. Antibiotic-loaded, PMMA bone cement is then loaded into the 
mold, and a pre-fabricated, custom DePuy revision femoral stem is inserted into the bone cement 
and allowed to cure before being placed into the body. The use of the Prostalac Hip System has 
proven advantageous in that it allows for early weight bearing, and because it provides an articulating 
system, the functional movement of the hip is retained (Scharfenberger, Clark, Lavoie, O’Connor, 
Masson & Beaupre, 2007). Researchers have further estimated that the Prostalac Hip System has an 
89-96% success rate assuming that the surgeon follows protocol (Biring et al., 2009). While the 
Prostalac Hip System is known to be highly successful, it also bears a variety of disadvantages and 
places in which improvements can be made. As previously stated, the Prostalac Hip System is 
manufactured by DePuy, and therefore, it is only compatible with the other DePuy products and the 
reinforcing stems provided in the kit. The Prostalac Hip System is produced to be a reusable medical 
device, meaning that in between subsequent procedures, each component within the kit must be 
sterilized. If sterilization procedures are not then properly executed, contamination and introduction 
of foreign tissues between patients may occur and could impart detrimental health complications 
(Rutala & Weber, 2004). Additionally, the kit is expensive, meaning that most hospitals are not able 
to actively stock this kit as a readily available medical device. Because of this, hospitals often times 
have limited access to the kit, meaning that if a patient presents with an infected implant and 
requires revision surgery, they may need to wait for the hospital to acquire the kit, leading to pain 
and discomfort for the patient (Prostalac Hip System – Surgical Technique, 2010). 
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Figure 6: DePuy Prostalac Hip System is one of the most effective revision hip replacement surgeries with a success rate of 89-
96%; (Prostalac Hip System – Surgical Technique, 2010. Retrieved from, http://gsortho.org/) 
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Table 1: Comparison of current products for treatment of infected hip arthroplasties and the pros and cons of each 
 
 
Current Procedures Pros Cons 
Tecres Temporary Spacer 
 
1. Ease-of-use 
2. Efficient 
1. Partial Weight Bearing 
2. Number of sizes limited 
3. Non-specific broaches 
InterSpace Hip 
 
1. Six different stem sizes 
2. Designed for greater 
surface area 
1. Partial weight bearing 
2. Non-specific broaches 
Biomet StageOne Select 
 
1. Provided silicone mold 
system 
2. Single use/disposable 
1. Absence of broaches in kit 
2. Brand specific (Only 
Biomet products) 
DePuy Prostalac 
 
 
1. Six specific broaches 
2. Early weight bearing 
3. 89-96% success rate 
1. Only usable with DePuy 
Products 
2. Reusable (Sterilization 
needed before and after 
each use) 
3. Not easily accessible 
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2.2.4 Project Need 
 Based on our research, we identified that there is a need to create a novel surgical system to 
address the shortcomings of the revision products already available on the market. During personal 
conversations with Dr. John Wixted, we learned that there exists only one kit to treat infected hip 
implants in New England. This leads to further pain endured by the patient if two hospitals need to 
perform a two-stage arthroplasty on the same date, or if the surgeon detects the infection while 
performing surgery for what he/she thinks is a mechanical failure. Additionally, this kit contains 
materials and components that are specific to the DePuy brand of hip replacements. Since the kit 
contains components such as hip stems that are only compatible with the Prostalac Hip System, the 
price of the kit is driven up. Although the surgeon may only lease the kit for 1-2 days at a time, the 
hospital must pay a total of $5,400+ in order to use the hip stem, acetabular cup, and head included 
in the kit for the revision surgery. Further, before each use, this kit must be sterilized which can lead 
to a variety of shortcomings previously outlined. Due to these shortcomings, we aim to produce a 
kit that will increase the accessibility of septic revision kits to surgeons, will be adaptable to various 
companies’ components which are already available to surgeons in-house, and will be comprised of 
disposable components to eliminate the need for subsequent sterilization processes. 
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Chapter 3: Project Strategy 
The primary goal of our project is to produce a kit to facilitate orthopedic surgeons in 
performing two-stage revision hip arthroplasties. The purpose of this chapter is to explain the 
process by which our objectives and constraints were devised and the initial client statement was 
revised to meet our objectives and constraints.  
3.1 Initial Client Statement 
The initial client statement that was provided by Dr. John Wixted is summarized below. 
Based on this statement and the information provided, we devised a list of objectives and 
constraints to guide the direction of our project.  
“When joint replacements become infected, the standard of care is to use an antibiotic impregnated cement 
coated implant. We envision a kit for broaching the femoral canal and molding the cement around any 
existing implant. This will provide an off the shelf, disposable solution to an increasingly common problem. 
Joint replacement surgeries and revision arthroplasty are increasingly common. At least 1 in 200 of these 
becomes infected, requiring removal and treatment with antibiotics. Temporary components, covered with 
antibiotic impregnated cement, are used as spacers prior to reimplanting a new component. 
However, most hospitals do not stock the equipment to easily mold the cement around a prosthesis, nor do 
they have broaches to match the molds. This generally requires making arrangement with a manufacturer to 
bring this equipment to the hospital, and can result in delays in care and difficulty scheduling surgery for what 
are frequently unanticipated infections. 
Providing a disposable, one time use kit which contains the necessary equipment to make such a temporary 
component would greatly simplify this process. The kit should contain disposable broaches and a simple mold 
system for creating these temporary prostheses. Most hospitals readily stock standard prostheses, and any 
implant small enough to fit into the mold would work for this purpose. In addition, matching plastic liners 
are also readily stocked by hospitals, making the process of dealing with infected joint replacement patients far 
easier. 
A simple, one time use, disposable kit would facilitate surgical management of infected joint arthroplasties. 
Any hospital which performs joint arthroplasty must be prepared to deal with prosthetic infections. An off the 
shelf solution is much more preferable for the surgeon and the hospital than having to make arrangement for 
specialized instrumentation to be brought into the hospital for infrequent use.” 
3.2 Objectives and Constraints 
3.2.1 Objectives 
Having analyzed the initial client statement, our team generated an objectives tree, shown in 
Figure 7, as a means to illustrate our project goals and objectives. We concluded that the components 
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of the kits must be accessible, accurate, reliable, universal, user-friendly, disposable, marketable, and 
manufacturable.  
Our project must be accessible to the orthopedic surgeon for immediate use in the operating 
room. Since there is only one kit for the surgical management of a two-stage revision arthroplasty in 
New England, it is oftentimes double-booked, in which case one of the surgeon’s patients must wait 
and resultantly endure further physical and mental pain. Also, if the surgeon had begun to perform a 
revision arthroplasty due to possible mechanical failure and he realized that the implant site had 
become infected, then it is crucial that he have the necessary equipment accessible to him almost 
immediately in order to perform the two-stage revision arthroplasty. 
The surgical instruments comprising the kit must be accurate and reliable. Regarding the 
project scope, the accuracy of the system refers to how closely the space broached in the femoral 
canal matches its predefined dimensions; additionally, it refers to how effectively the mold system 
forms the antibiotic-loaded cement spacer and accounts for a press fit into the femoral canal. With 
respect to the reliability of the broach and mold system, we must consider the strength and 
durability of the kit’s components. The mold system, for example, must retain its structural integrity 
and shape upon injection of the bone cement and therefore must be strong and durable. To ensure 
the broach can withstand the force exerted by the orthopedic surgeon without deforming or 
fracturing following several strikes of the mallet, its durability must remain constant for the length of 
the procedure.  
The kit must also be universal, meaning that the broaches and mold system must 
accommodate the variety of hip stems that are on the market. Currently, the kits that are used in 
two-stage revision hip arthroplasties are brand-specific. The kit by DePuy, for example, only 
accommodates the reinforcing stem manufactured by DePuy. For the purpose of our project, we 
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would like our kit to be compatible with BioMet, DePuy, Stryker, and Zimmer stems since these 
stems are the most readily used and stocked by UMMC.  
Further, we aim for our kit to be composed of disposable components. Currently, the kit 
used by UMMC is the DePuy Prostalac Hip System, which consists of non-disposable broaches and 
molds. Therefore, the components of the Prostalac Hip System must undergo sterilization following 
each revision procedure. Unfortunately, if sterilization procedures are not performed properly, 
foreign material left behind from the prior procedure could be introduced to a patient receiving a 
revision when performing a subsequent procedure. This could lead to detrimental health 
complications for the patient undergoing the revision procedure. Additionally, the need for 
sterilization imparts an additional expense to the cost of use for the kit, further necessitating the 
disposability of our kit. By ensuring that our kit is disposable, its ease of use is enhanced and the 
overall cost of the procedure can be decreased. In order for our kit to be disposable, the materials 
chosen for the surgical instruments and their manufacturing processes must be inexpensive relative 
to the current cost of using the Prostalac Hip System.  
The marketability of our kit is an important factor to consider in order to distinguish our 
product from the kits already on the market to convince consumers of the advantages of our 
product. Key components that separate our kit from those currently on the market are that it is, 
accessible, disposable, inexpensive, and universal. The current gold standard, the Prostalac Hip 
System, is expensive to manufacture and use. Because UMMC is required to bring in the system 
upon scheduling a septic revision procedure and then sterilize the kit after each use, it can impart a 
significant financial burden on the hospital. Currently, there is only one Prostalac Hip System in 
New England, which makes the increased accessibility of our kit appealing to the consumer. The 
goal of our project is to design a kit that is both disposable and inexpensive such that it can be 
readily stocked in hospitals for immediate use. Since our kit will be disposable, the materials that 
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comprise the broaches and molds must be inexpensive to ensure our kit costs less than the current 
cost of bringing in the Prostalac Hip System. Lastly, the universality of the kit will appeal to a 
number of orthopedic surgeons because they can use the variety of stem brands stocked on their 
shelves as opposed to purchasing the higher cost reinforcing stem provided in the kit by DePuy.  
Depending on the materials we choose for the broaches and molds, the manufacturing 
method of the kit may vary. For example, a certain material may be better suited for 3-D printing 
whereas another may be more easily manufactured by means of injection molding. We would like 
for our kit to consist of fewer components than the Prostalac Hip System, meaning that there are 
fewer detachable or moving parts, to increase its ease of use, simplify its manufacturing, and 
augment its reproducibility. Additionally, to identify which objectives were most important to our 
client, Dr. Wixted, we provided him with a pairwise comparison chart, and he ranked the objectives 
by importance. This chart can be seen in Table 2. Table 3 shows the order of importance our client 
assigned to each objective. Further, Tables 4-7 illustrate rankings of our sub-objectives to assist us in 
assessing the success of our final product.  
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Figure 7: Objectives Tree 
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Table 2: Pairwise Comparison Chart
 
 
Table 3: Ranked Objectives 
Objective Scores 
1. Accuracy 6.5 
2. Reliability 6 
3. Accessible 4.5 
4. Universal 4 
5. User-Friendly 2.5 
6. Disposable 2.5 
7. Marketability 2 
8. Manufacturability 0 
 
Ranked Secondary Objectives 
Table 4: Ranked Secondary Objectives for Reliability 
Reliability 
   
 
Durable Strength Scores  
Durable 
 
1 1 
Strength 0 
 
0 
 
Table 5: Ranked Secondary Objectives for User-Friendly 
User - Friendly  
   
 
Ergonomics Efficient Scores  
Ergonomics 
 
1 1 
Efficient 0 
 
0 
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Table 6: Ranked Secondary Objectives for Marketability 
Marketability  
    
 
 
Inexpensive  Accessible Disposable Universal  Scores  
Inexpensive 
 
1 0 0 1 
Accessible  0 
 
0 0 0 
Disposable  1 1 
 
0 2 
Universal 1 1 1 
 
3 
 
Table 7: Ranked Secondary Objectives for Manufacturability 
Manufacturability 
   
 
Reproducibility Few Components Scores  
Reproducibility 
 
1 1 
Few Components  0 
 
0 
 
3.2.2 Constraints 
The following constraints limit the design space in that we are required to abide by them for our 
project to be deemed successful. Our kit therefore: 
 Must be biocompatible for implantation in the human body  
 Must be sterilizable over time without negatively affecting its initial mechanical and chemical 
properties 
 Must cost less than the DePuy Prostalac Hip System  
 Must be completed within one academic year 
 Must remain within the allotted MQP budget ($1,624)  
Because of the health risks associated with materials for implantation, we must ensure that our 
kit does not elicit a biological response within the body to guarantee patient safety. With this in 
mind, we must also be cognizant of the sterilizability of the materials in question. Just prior to use in 
the operating room, all components of the kit will have to be sterilized; for this reason, we must 
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ensure that the method of sterilization does not induce an adverse mechanical or chemical response 
in the materials we choose for the broaches and molds. If we were to utilize steam sterilization for 
the purpose of sterilizing the kit, for example, we would carefully select highly heat resistant 
materials for the broaches and molds.  
 Having devised our objectives and constraints, we revised the initial client statement such 
that it consolidated our project aims and goals.  
3.3 Revised Client Statement 
After further analyzing the initial client statement and speaking with Dr. Wixted, a revised 
client statement was devised to accurately depict his needs and wants and to explicitly state his 
expectations for the project: 
“Design a low-cost, easy-to-use kit to facilitate the surgical management of infected joint replacement surgeries 
and revision arthroplasties. The kit must be accessible to the surgeon for immediate use in the operating room, 
appropriate for single-use applications, and capable of accommodating a variety of commonly used brands and 
sizes of hip implants. The kit must be designed such that either the equipment necessary for broaching the 
femoral canal is provided, or the molding system must allow surgeons to use broaches already in stock in the 
hospital to form the temporary antibiotic-loaded cement spacer.” 
3.4 Project Approach 
 We devised a list of specific aims in order to direct our efforts in accordance with the 
objectives set forth by our revised client statement. Our preliminary aims were:  
 To select a material for the broach that can cut through the cancellous bone of the femur 
without failure.  
 To select a material for the mold that would not adhere to the bone cement or leave behind 
a residue on the mold-PMMA interface.  
 To devise a set of dimensions for a variety of sizes of matching broaches and molds such 
that their dimensions could accommodate for the aforementioned prosthesis brands. 
 
To achieve these specific aims, we propose a method in which we will perform extensive 
material research to determine, for the purpose of producing a broach, what materials exist that have 
the capacity to cut through cancellous bone, and offer a reduced material cost when compared to 
stainless steel. Utilizing mechanical testing such as Instron impact tests, we can determine the 
efficacy of this design and failure mechanisms to address.  
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Further, we must research materials that display non-adhesive properties to be used for the 
construction of a mold system. Following document research, we can then test adhesive properties 
through visual analysis of a cement component formed within the given mold material.  
We can then obtain information relating to the dimensions of existing hip stems to ensure that our 
kit can accommodate for a variety of different hip stem dimensions that exist on the current market.  
A variety of mechanical testing to prove structural integrity and safety, such as the 
aforementioned Instron impact testing, will be performed to illustrate the safety of this product. 
Further biocompatibility testing will be performed such as direct contact cell culture and live/dead 
staining to prove the materials being used will not elicit any unwanted biological response. Lastly, 
financial analysis will be done to show this system is more cost effective than current systems as 
well.    
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Chapter 4: Alternative Designs 
 Based off of our objectives and constraints, several design alternatives were created to meet 
our client’s need. The first design alternative included creating a full set of disposable broaches and 
molds that had dimensions to accommodate for a number of prostheses brands. Our second design 
alternative included making a set of molds that had dimensions to accommodate for a number of 
prostheses brands, allowing the surgeon to use the broaches he/she has on shelf. Our third design 
alternative included making customizable molds by utilizing 3-D scanning technologies to create 
molds with the exact dimensions of those hip stems and broaches already on a surgeon’s shelf. 
4.1 Disposable Broaches and Molds 
4.1.1 Design 1: Broach with Detachable Handle 
 First, we considered a design, shown in Figure 8, for which the handle was detachable and 
interchangeable between a set of varying size femoral broaches. 
  
Figure 8: Surgical broach with detachable handle 
This design could be advantageous provided that the reusable handle and assorted femoral 
broach components could significantly reduce the cost of the material of choice since it is less 
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massive. However, this design would nearly double the number of components that we would 
include in the kit, which may increase its manufacturing cost and decrease its simplicity and ease of 
use.  
4.1.2 Design 2: Single Component Broach 
With respect to the femoral broaching component of our project, our second alternative 
design entailed a single component, which we had intended to be disposed of postoperatively. Our 
preliminary broach design was based on the simplest broach design that we had concluded was the 
most commonly utilized broach by orthopedic surgeons for the purpose of a total hip arthroplasty. 
Our goal was to reverse engineer the design, shown in Figure 9, which entails a single component 
consisting of a handle welded to the femoral broach. 
 
Figure 9: Single component surgical broach 
By choosing a plastic that has mechanical properties (i.e., hardness, Young’s modulus, 
compressive strength, and fracture toughness) greater than those of cancellous bone, we intended to 
produce a set of broaches that were significantly less expensive than the set of broaches 
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accompanying the DePuy Prostalac Hip System. The aforementioned design is particularly 
advantageous in that it comprises a single component and is prepared for immediate use by the 
orthopedic surgeon upon removal from its packaging. Additionally, the set of broaches would be 
inexpensive such that the surgeon could dispose of them following a two-stage revision arthroplasty. 
Upon completion of the SolidWorks model of the broach, a model of the mold could then be 
drafted to ensure that the temporary component formed from the mold would press fit into the 
broached femoral canal.  
4.2 Utilizing Stocked Surgical Broaches 
 Another design alternative would be to suggest that surgeons utilize the broaches that they 
already have in stock in their respective hospitals. This would be advantageous in that these 
broaches have already been approved for surgical procedures. In this iteration, we identified two 
options. It is important to note that these designs were not conceptualized until after the preliminary 
testing period when we determined the scope of our design needed to shift. 
4.2.1 Design 3: Templates 
 The first option is to create one set of molds that accommodate for the varying dimensions 
of a number of prostheses brands. Through dimensional analysis and relation, we would then be 
able to provide a compatibility chart, carefully depicting which size of which brand of broach would 
be accommodated for by which mold. This document would be provided in the surgical kit for the 
orthopedic surgeon to refer to in the midst of the procedure.  
4.2.2 Design 4: Customizable Molds 
 The second option is to create an entirely customizable kit, whereby each orthopedic 
surgeon could provide a set of the hip stems they utilize for a total hip arthroplasty for analysis. The 
stems would then undergo 3-D scanning to create a point cloud. This rendering would be converted 
to a SolidWorks model, and then a 3-D printed negative mold would be created. This negative mold 
would then be placed in PDMS for 24 hours until the PDMS had cured. The negative mold could 
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then be removed, and the PDMS mold could be sterilized to allow individualized, customizable 
molds to be provided, specific to the stems each surgeon uses, thus enabling the surgeon to use the 
broaches compatible with that given stem size. This option is particularly advantageous in that the 
orthopedic surgeons would be able to use the same broaches they use in a primary total hip 
arthroplasty, meaning that they would not have to become accustomed to relying on a new device.   
 4.3 Initial Chosen Design 
  Based on comparing the different design alternatives, our team initially decided to 
move forward with Design 1: Disposable Broaches and Molds, since this design iteration matched 
most closely with the desires outlined by our client. Since the single component broach was more 
feasible, we explored designing this iteration.  
Because we wanted this design to be disposable, we investigated the option of forming both 
the broaches and molds out of a polymer material. A patent search was conducted to ensure the 
novelty of this design option. While existing patents proposed alternative broaching modalities, none 
were found that explored the use of polymers for the broach material. 
Various preliminary testing procedures were carried out to create the broaches and molds, 
determine viable material selection, and determine whether or not this option could be a more cost 
effective method than that already put forth by the Prostalac system. We originally decided to pursue 
the option of generating SolidWorks models (Figure 11) for a set of customizable broaches because 
our initial client statement stated that our kit must contain a set of broaches and molds. Because we 
were unaware of other resources that existed at the time we chose this option, we continued the 
processes of dimensional rendering, and SolidWorks modeling. Using existing templates that 
outlined the dimensions of stems manufactured by Smith & Nephew, Biomet, and Stryker (shown in 
Figure 10), we were able to determine appropriate dimensions that would accommodate for a variety 
of different stems already available on the market. However, after using these dimensions and 
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spending several weeks drafting the model of the broach in SolidWorks that manually modeling the 
broach in SolidWorks may be unfeasible given our constraints. Of even greater concern was our 
discovery of the price it would cost to manufacture the broaches even with a viable SolidWorks 
model. We learned that our design would have to be outsourced to an external company to ensure 
the proper dimensions and details of our design which would ultimately make our design even more 
expensive than the use of the current kit. 
 
Figure 10: Surgical template overlays used for determination of dimensions 
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Figure 11: 3-D SolidWorks model of initial broach and mold design 
Further validating that our device would be unfeasible to pursue in this manner, we obtained 
rods of various polymers into which we manually cut different teeth orientations. These test 
broaches were then used to attempt to cut through wooden dowels and both cancellous and cortical 
bone (shown in Figures 12 and 13). Although the mechanical properties of these polymers were 
higher than that of cancellous bone, we did not consider that the surgeon would have to cut through 
some cortical bone during the surgery. Therefore, it is logical that the rods tested could not cut 
through the porcine femur. We determined that the mechanical properties of the polymers that we 
had chosen for the broaches are not sufficient enough for the purpose of effectively broaching the 
femoral canal.  
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Figure 12: ABS teeth and result of sawing wooden dowel with this instrument 
 
 
Figure 13: Porcine femur cut with ABS teeth (negligible damage to cortical bone) 
 
Due to these shortcomings, new methods and considerations had to be devised.  
The procedure we followed to come to this conclusion can be found in Appendix A. We 
reconsidered our design alternatives, which would allow surgeons to utilize surgical instruments 
already in stock in the hospital, and compared this to this initial chosen design. 
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4.4 Conceptual Final Design 
 Our three design alternatives were evaluated primarily on surgical practicality, brand 
specificity, and cost to devise a conceptual final design as seen in Tables 8-10. 
4.4.1 Surgical Practicality 
Table 8: Ranked designs based on surgical practicality with 1 being the best option 
Design Rank 
Injection Mold Broach 3 
Compatibility Chart 2 
Custom Molds 1 
 
 The kit that provides the compatibility chart and the entirely customizable kit are more 
surgically practical than the injection mold broach. Orthopedic surgeons are already accustomed to 
using specific instruments and may be apprehensive about utilizing an instrument that may perhaps 
be made of a material they have not previously worked with. Additionally, the broaches used for 
total hip arthroplasties have already been proven effective for broaching the femoral canal, thus 
making the implementation of either option more likely. Ultimately, the customizable kit was ranked 
with the highest surgical practicality because, having spoken with orthopedic surgeons at UMMC, we 
realized that many prefer a specific prosthesis brand and model; the customizable kit would allow 
the surgeons to continue to use their preferred broaches and hip stems that they have sworn by for 
years.  
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4.4.2 Brand Specificity 
Table 9: Ranked designs based on brand specificity with 1 being the best option 
Design Rank 
Injection Mold Broach 2.5 
Compatibility Chart 2.5 
Customizable Kit 1 
 
The customizable kit is undoubtedly the most brand-specific in that a mold can be tailored 
to any brand and model of broach that a surgeon may wish to use. Both the injection mold broach 
and the kit that provides the compatibility chart are simply designs we based on a compilation of 
select broach or hip stem designs and dimensions. In doing so, we did not account for all brands 
and models of broaches and hip stems, which would likely result in a mismatch between the 
dimensions of the broach and those of the temporary component. A customizable kit would suggest 
that truly every prosthesis brand could be accommodated for to ensure that the temporary 
component that is formed matches the dimensions of the femoral canal into which it would be 
introduced shortly after broaching.  
4.4.3 Cost  
Table 10: Ranked designs based on cost with 1 being the best option 
Design Rank 
Injection Mold Broach 3 
Compatibility Chart 1 
Customizable Kit 2 
 
 The kit providing the compatibility chart would undoubtedly cost the least to manufacture. 
The most predominant cost would be that of the 3-D printed molds and a laminated copy of the 
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compatibility document for surgeons to refer to during the procedure. The customizable kit would 
be more expensive because not only would the rendered hip stems have to be 3-D printed, but the 
hospital would also incur a cost for having their specific prostheses molds customized. The injection 
molded broach would likely be the most expensive on account of the costs associated with injection 
molding and the fact that the kit would comprise both broaches and molds. Since our kit is intended 
to be disposable, it is important to bear in mind all associated costs that may make an alternative 
design unfeasible.  
4.5 Chosen Design 
 Based on careful analysis, we were able to choose our final design. On account of its high 
degree of surgical practicality, customizability, and relatively modest cost, the customizable kit design 
alternative was selected as our final design. Preliminary testing was conducted in order for us to 
realize a conceptual final design and to determine the material for the mold system and the accuracy 
with which the 3-D scanner collects a point cloud and renders a 3-D solid model of the hip stem.  
 A patent search was again conducted to validate that this design alternative was a novel 
approach to this problem. Based on a lack of patents addressing this methodology of reverse 
engineering, we determined that we could pursue this option as no current products were on the 
market. 
4.5.1 Revised Project Approach: 
 Based on the new direction of our project, we found it vital to create a new list of specific 
aims more relevant to our new design alternative. We devised a list of specific aims in order to direct 
our efforts in accordance with the newly focused objectives of the new design alternative. Our 
revised aims are:  
 To create a molding system that allows surgeons the use of their own, stocked surgical 
equipment. 
 To create molds that can be customized to the shape and dimensions of any given hip 
implant on the market.  
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 To select a material for the mold that will not adhere to the bone cement or leave behind a 
residue on the mold-PMMA interface.  
 
To achieve these specific aims, we propose utilizing 3-D scanning technologies to provide a 
rendering of a solid model that replicates the dimensions of any given implant stem, precisely. We 
then propose printing this rendering using a 3-D printer. The 3-D printed component would then 
be used to develop a mold, by curing a molding material around it, with the exact dimensions of the 
original stem. The space created in the mold material can then be filled with bone cement and a 
smaller primary stem to aid with structural integrity. As with the initial project approach, direct 
contact cell culture techniques and live/dead staining can help to prove that this device is as safe as 
existing products on the market.  
Then, utilizing various analytical and statistical analyses, we can prove that our developed design 
is as efficacious as the existing Prostalac system, while also allowing for the benefits of 
customizability, greater surgeon accessibility, and a reduced cost.   
4.6 Preliminary Experimentation 
4.6.1 Efficacy of 3-D Scanning  
 To determine whether or not 3-D scanning would be an efficacious means of creating a 
model with the same dimensions of the original hip stem, we obtained a femoral stem from Dr. 
Wixted to perform some preliminary feasibility tests. The way in which the 3-D scanner works is by 
a method of laser triangulation measurements during which, a laser line is passed across an object. 
The laser reflected off of the object is then picked up by a sensor, located at a known angle and 
distance from the laser source. Based on the angle at which the laser is returned to the sensor, the 
specific distance between the object and camera can be discerned. Then, trigonometric triangulation 
allows the software to calculate distances and create a point cloud of data representing the point 
locations of the edges of the scanned object.  
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With this in mind, we utilized the 3-D scanning technologies (Konica Minolta Range 7) at 
the College of the Holy Cross in Worcester, MA, where we obtained several scans of the implant 
utilizing their Rapidform scanning software. With this software, we were able to roughly determine, 
using calipers and a measuring function in the Rapidform software, that it appeared that the 3-D 
rendering of the implant displayed the same dimensions as those of the original implant. We 
subsequently concluded that this method of rendering a 3-D model would be both feasible and 
seemingly efficacious while providing a means to produce results that would be able to be replicated 
for any given hip stem. We concluded that we could proceed with more in-depth testing and data 
acquisition based off of the preliminary successes of accurate data collection through the use of 3-D 
scanning.  
4.6.2 Determination of Efficacious Mold Material: PDMS   
 We conducted preliminary adhesive tests to determine whether or not the chosen material 
for our mold would adhere to materials similar to bone cement. Based on previously conducted 
research, we determined that polydimethylsiloxane (PDMS); a silicone based elastomer that is used 
quite regularly in mold-making and known for its non-adhesive properties, can be steam sterilized 
and is biocompatible. We carried out some preliminary testing to conceptualize whether or not 
PMMA bone cement would in fact, not adhere to the mold surface if it were made out of PDMS. 
To do so, we made a solution of PDMS and allowed it to cure in a 60-degree oven overnight. We 
then mixed the components of an epoxy grout for use as a cost-effective alternative to PMMA bone 
cement. Small holes were cut out of the PDMS disk, which were subsequently filled with the epoxy 
grout. Grout was also placed directly on the flat surface of the PDMS and allowed to cure overnight. 
The following morning, the grout was removed from the PDMS mold; dust left behind by the grout 
was the only visible residue remaining on the PDMS disc, thus indicating the non-adhesive nature of 
PDMS. The results are portrayed in Figure 14. 
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Figure 14: PDMS visual adhesive testing proved to be a success since only dust particles remained on the surface 
4.7 Moving Forward 
 With the success of our preliminary experimentation, we confirmed that our third design 
alternative, customizable molds, would be our final design. 
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Chapter 5: Final Design & Validation 
 After several design revisions, we went into the production and validation stage of our final 
design with the following specific aims: 
 To create a molding system that allows surgeons the use of their own, stocked surgical 
equipment 
 To create molds that can be customized to the shape and dimensions of any given hip 
implant on the market  
 To select a material for the mold that will not adhere to the bone cement or leave behind a 
residue on the mold-PMMA interface  
 To achieve these specific aims, we propose a method with which 3-D scanning and printing 
technologies can be used to improve upon the current technologies available for two-stage revision 
hip arthroplasties. To do so, we utilized the following methods and procedure.  
5.1 Image Processing 
 A hip implant was obtained from Dr. Wixted to begin the testing procedure. Utilizing a 
Konica Minolta Range 7 3-D scanner, we obtained over fifteen scans of different angles and views 
of the hip implant in order to construct a viable solid model. Images for this process can be seen in 
Figure 15. The scans are processed as a point cloud, meaning that due to the laser triangulation that 
occurs in the system, various points in xyz coordinates could be obtained, indicating the surface 
topography of the implant. The more faces that can be obtained and meshed together, the more 
accurate the final model will be, as this will produce a greater number of points in the meshed point 
cloud, thus leading to a more accurate 3-D model. The individual face scans were then stitched 
together using Rapidform scanning software, assembled in conjunction with the laser camera. This 
created a complete point cloud representing the entirety of the solid hip implant. This file was then 
saved as a .rgv file for further processing. 
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Figure 15: 3-D scanning of femoral stem 
 
 The faces comprising the complete point cloud were then uploaded into MeshLab software. 
Using this software, a variety of different image processing techniques had to be followed. First, the 
fifteen different point cloud faces were meshed together so that one solid point cloud now existed. 
Next, the point cloud was processed through a subsampling filter, known as Poisson-disk sampling. 
The sample number was input as the number of points in the point cloud. Normal reconstruction 
was then performed; the normals were then computed for the point set; the number of neighbors 
was set to 20. Next, a surface reconstruction was performed using a Poisson triangulation, in which 
the octree or recursion level was set to 11 to maintain high resolution. A remeshing, quadratic edge 
collapse was then used to simplify the component by removing unnecessary triangulations or faces. 
Next, the object was made manifold, such that the existing faces did not overlap one another. 
Finally, the hole filling function was used in order to ensure that a solid object was formed. This file 
was subsequently saved as a .stl file (Figure 16). This file could then be read and processed for 3-D 
printing.  
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Figure 16: 3-D rendering of hip stem formed through meshing 3-D scans in MeshLab 
5.2 3-D Printed Model 
 The .stl file was then used to 3-D print a negative mold to be used for the formation of the 
PDMS mold with dimensions exactly that of the original hip stem. This is seen below in Figure 17. It 
is important to note that 3-D printing the stem rather than simply curing a PDMS mold around a 
normal, metal hip implant is of vital importance to the overall cost effectiveness and potential 
surgeon satisfaction. Simply using a primary stem directly, around which to cure PDMS would incur 
much higher costs in that in order for the system to accommodate all existing hip stems, we would 
need to obtain a set of all the primary stems on the market, which is financially unfeasible; even if a 
surgeon were to provide the stems to be used to create a mold of those specific dimensions, this 
may be an inconvenience for surgeons. Additionally, following each procedure, whenever a mold 
would be used, the specific stem used to create that mold would have to be re-obtained in order to 
replace the mold used.  
 Using a 3-D scanned and 3-D printed model allows for a database of different implant 
brands and models to be created. Once a stem is in the database, its geometries can be accessed at 
any time, meaning that after a surgeon uses a mold, he may simply ask for a replacement, without 
again having to provide primary stems to be processed. Because of the creation of a database, 
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production time can be decreased while the ease of reproducibility increases. Furthermore, using a 3-
D printed mold from a 3-D scan allows for changes in hip implant technologies for the future; as 
the field of orthopedics continues to expand and change, it is important that the technologies used 
to address the associated problems are capable of adapting, simultaneously.  
  
Figure 17: 3-D printed component (right) compared to primary hip stem (left) 
 The full process for creating the 3-D printed component to use as a master template for the 
creation of the mold can be seen below in Figure 18. 
54 
 
 
Figure 18: Full process for 3-D scanning the hip stem; Step 1: Obtain hip stem (of an existing broach/implant set) from 
orthopedic surgeon, Step 2: Obtain scan of the stem using 3-D scanner, Step 3: Rotate stem to obtain scans of various planes, 
Step 4: Mesh the point clouds and convert to .stl file, Step 5: Rapid prototype negative template 
 
5.3 Mold System 
 After obtaining the 3-D printed component, the mold to form the PMMA bone cement 
component could be prepared. As the component is of a unique geometry and to ensure the 
integrity of the while the component was being removed, it was first coated. To coat the component 
so that PDMS did not stick to it and allow for easy removal, 50 uL of Trichloro (1H, 1H, 2H, 2H-
perfluorooctyl) silane (Sigma Aldrich) was placed on a 35 mm petri dish inside a vacuum desiccator 
inside a laminar flow chemical hood. The component was coated for 24 hours before removing.  
 PDMS was created by mixing 585 grams of base and 65 grams of curing agent.  The uncured 
PDMS was poured into a container and the 3-D printed component was then suspended in the 
PDMS, deep enough so the PDMS covered the parts of the stem that would otherwise be implanted 
into the femoral canal. The construct was degassed by placing it in a vacuum for 30 minutes. It was 
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then transferred into a 60 °C oven and allowed to cure for 24 hours.  After PDMS had polymerized, 
the component and mold were placed in a -20 freezer for one hour and then allowed to come to 
room temperature for one hour. The mold was then submerged in 70% ethanol. Following 
submersion (for 20 minutes), the component was slowly removed. Figure 19 shows the stem inserted 
in cured PDMS and the resulting mold after this process. 
 
Figure 19: Process for making PDMS molds 
5.4 Antibiotic-Loaded PMMA Bone Cement Component Construction  
 As the set of molds are what would be included in our kit, to emulate the process the 
surgeon would complete in the operating room, cement was mixed and loaded into the mold space 
of the cured PDMS. A wooden dowel, to replicate a primary implant that is smaller than the size to 
make the mold, was inserted into the cement and allowed to cure for 20 minutes (*Note bone 
cement would cure in ~4 minutes in the operating room). The PDMS was then cut away from the 
temporary spacer, and the component was then removed. Figure 20 shows the cement curing around 
the wooden dowel to use as a proof of concept for forming the temporary spacer that would be 
implanted in the patient’s body. 
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Figure 20: Proof of concept for forming the temporary spacer  
 The full process for creating the mold and temporary spacer can be seen below in Figure 21. 
 
Figure 21: Full process for making the mold and temporary spacer; Step 1: Obtain negative template, Step 2: Fill container with 
PDMS, insert component, and allow it to cure, Step 3: Remove component from mold and place mold in respective kit, Step 4: In 
the operating room, fill mold with bone cement and insert smaller size stem allowing cement to cure around the stem, Step 5: 
Insert the temporary component into the body 
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5.5 Validation 
 Following antibiotic-loaded PMMA bone cement component construction, dimensional 
analysis was performed. Using precision calipers, dimensions of the bone cement component were 
taken and compared to dimensions taken at the same location on the metal primary implant. These 
dimensions were then analyzed via an ANOVA single variable test to prove whether or not the 
cured component had dimensions close to those of the primary implant.  
 A cytotoxicity test was also carried out to ensure that our process did not cause possible 
leaching of cytotoxic substances onto the bone cement implant. An elution cytotoxicity test was 
performed in accordance with ISO standards with a positive control, negative control, and an 
experimental group. A live/dead stain using propidium iodide and Hoechst was then used to 
determine proportion of live to dead cells in each culture dish, to determine if any cytotoxic effects 
may have been incurred during our process.   
 Lastly, a visual surface analysis was performed to determine whether or not the PDMS stuck 
to the PMMA component following removal from the mold. This was done using a specimen 
microscope to see if more macroscopic amounts of PDMS could be seen on the removed PMMA 
component.  
 Chapter 6 goes into our results for these tests and explains our methodology in greater detail. 
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Chapter 6: Design Verification 
 To verify the efficacy of our design for the use in two-stage revision hip arthroplasties, a 
variety of imaging and testing procedures were performed and analyzed. The results of these tests 
are discussed below.  
6.1 Dimensional Analysis 
 As discussed in the previous chapter, 3-D scans were taken of the provided hip implant, 
rendered into a solid component using image processing software, and 3-D printed. This device was 
then used to create a PDMS mold with a space resembling the exact dimensions of the 3-D scanned 
component. For a proof of concept, cement was then used to fill the mold, and a supporting dowel 
was submerged in the bone cement until it cured as seen in Figure 22. This dowel was used to 
function like the smaller metal stem a surgeon would be placing in the mold during the procedure. 
Because it is vital to the success of our device that the temporary component exhibits dimensions 
precisely to that of the original hip stem, it was necessary to prove that this was in fact the case.  
 
Figure 22: Mold filled with cement and a supporting wooden dowel, as a proof of concept for the process to form a temporary 
spacer in the operating room 
 To do so, we obtained comparative measurements of the original hip stem and the 
temporary spacer formed from the mold. We took several measurements along the hip implant in 
1cm increments for the back, side, and front faces using precision calipers. The raw data for these 
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dimensions can be found in Appendix B. This information was then analyzed, and the results can be 
seen below in a side-by-side comparative bar graph comparing the measurements obtained for the 
original implant dimensions versus the dimensions of the formed PMMA temporary component in 
Figure 23, 24, and 25 respectively.
 
Figure 23: Dimensions obtained for the Back Face comparing the temporary spacer and original hip stem 
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Figure 24: Dimensions obtained for the Side Face comparing the temporary spacer and original hip stem 
 
Figure 25: Dimensions obtained for the Side Face comparing the temporary spacer and original hip stem 
 A single-variable ANOVA test was carried out to determine if there was a statistical 
significance between the resulting temporary spacer and the original hip stem. After taking several 
measurements along the front, back, and side faces of the components, the data was compared and 
for each face a p-value of greater than 5% was obtained. These values can be seen in Table 11. This 
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proves that there is no significant difference between the original hip stem that was used to 3-D 
scan, and the cement spacer formed from the mold. 
Table 11: Calculated p-values after running an ANOVA test on the back, side, and front faces of the temporary spacer vs. the 
original hip stem 
Back Face Side Face Front Face 
0.985 0.537 0.617 
6.2 Microscopy Analysis 
 We wanted to ensure that a significant amount of PDMS from the mold would not be left 
behind as residue on the temporary component once that component was removed from the mold. 
To ensure this, we performed a visual analysis of the cured component using a specimen scope. 
Figure 26 shows the cement spacer under the specimen scope.  No PDMS was visibly seen on the 
surface of the component. It could be concluded that the spacer would be safe to implant inside the 
body after being formed from the PDMS mold.  
 
Figure 26: Temporary spacer under a specimen microscope, proving that no PDMS adhered to the component 
6.3 Sterility & Cytotoxicity Testing 
 In order to ensure that our device was safe for use in the operating room, it was necessary 
that we test that the PDMS mold created through our proposed process would not impart any sort 
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of cytotoxic residue onto the PMMA spacer before the temporary component's implantation into 
the human body. Sterility tests in accordance with ISO 10993-5: Biological evaluation of medical 
devices - Part 5: Tests for in vitro cytotoxicity were performed (ISO, 2009).  
Several modifications were made to this test modality based on the availability of materials; 
specifically, instead of L-929 mouse fibroblast cells, NIH/3T3 mouse fibroblasts were propagated 
and maintained in a 6cm dish until the time of experimentation. The cells were maintained and 
subcultured every three to four days when the cells had reached about 80% confluence. Cells were 
fed and cultured in single strength Minimum Essential Medium was supplemented with 5% fetal 
bovine serum (FBS) and 2% penicillin/streptomycin supplements (1X MEM), and were stored in a 
gaseous environment of 5% carbon dioxide (CO2) at 37C (ISO, 2009).      
 An in vitro elusion cytotoxicity experiment was developed to show whether or not the final 
product manufactured by our device would incur cytotoxic effects to the environment. The positive 
control for this experiment was latex, the negative control was unmodified PDMS, and the 
experimental group was antibiotic loaded bone cement (Simplex P, Stryker Orthopedics) that had 
been cured on PDMS that had been prior cured around a 3-D printed, ABS plus component, the 
same as is used in the negative mold of our device. These materials, including the latex, unmodified 
PDMS, and experimental PDMS were then either removed from sterile packaging, or sterilized using 
an autoclave.  
In a laminar flow biosafety hood, gentamycin-loaded bone cement was cured on the PDMS 
in the location where the plastic component had been, prior. The PMMA bone cement was allowed 
to cure for about ten minutes to emulate the time it would take to cure during surgery. The resulting 
piece of PMMA was then removed from the PDMS construct and was used as our experimental 
group in the cytotoxicity test. 
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 The test materials were then placed in a sterile 6cm dish, and 1X MEM was added to each in 
accordance with the U.S. Pharmacopoeia (USP) standards for the ratio of necessary eluding surface 
area to media. This ratio is defined as 60cm2:20mL; an eluding surface area of 60cm2  was obtained 
of each group and cultured in 20mL of single strength MEM, which will be referred to as elution 
media (Baker, 2007). The elusion media was allowed to incubate overnight. 
On the same day, a 12 well plate was seeded with 30,000 cells per well, to achieve 
appropriate confluence for this test, in 2mL of 1X MEM. Each well was seeded with cells because 
the procedure was run in triplicate. These cells were allowed to incubate overnight.  
After 24 hours of incubation, the elution media was harvested from the test materials. Media 
in the 12-well plate was removed, and 2mL of respective elusion media was added to each well. 3 
wells were also cultured with unmodified 1X MEM to add as an additional control to the 
experiment. The cells were observed and imaged every 24 hours for 3 days, as outlined in the ISO 
standards (ISO 2009). These images are seen below in Figure 27.  
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      PDMS (Negative Control)        Bone Cement (Experimental)    Latex (Positive Control) 
Figure 27: Visual analysis of cells after 24 hours (A-C) and after 72 hours (D-F), culturing in extraction media. A and D are 
culturing in media extracted from the negative control (unmodified PDMS). B and D are cultured in media extracted from the 
experimental group (modified PDMS). C and F are cultured in media extracted from the positive control (latex). All images taken 
at 20X with a 100um scale. 
After three days, a live-dead stain was additionally performed on the cells to test viability. 
Hoechst was used to stain for viable cells, which would appear blue, whereas propidium iodide was 
counterstained to identify dead cells, which would appear red or purple. This is an additional test not 
necessitated by ISO cytotoxicity standards, but we thought it would provide stronger visual 
evidence. The images from this procedure can be seen below in Figure28.  
24 
Hours 
72 
Hours 
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      PDMS (Negative Control)         Bone Cement (Experimental)     Latex (Positive Control) 
Figure 28: Live-dead stain of cells after 72 hours. Blue nuclear stain (Hoechst) indicates live cells, and red or purple nuclear stain 
(propidium iodide) stains dead cells. A and D were cultured in media extracted from the negative control (unmodified PDMS). B 
and D were cultured in media extracted from the experimental group (modified PDMS). C and F were cultured in media 
extracted from the positive control (latex). A-C are imaged at 20X and D-F are imaged at 40X. The scale in all images is 50um. 
It is evident by these images that there is a much higher density of dead cells in the latex 
wells than in the experimental wells or the controls, as was anticipated. Based on Table 12 below, 
used in evaluating cytotoxic response, a reactivity score of 0 was assigned to the negative control, 0 
for the experimental group, and a 4 for the latex.  
Table 12: Cytotoxicity reactivity chart (ISO, 2009) 
Grade Reactivity Condition of all Cultures 
0 None No cell lysis 
1 Slight Not more than 20% of cells are round, loosely attached; occasional 
lysed cells are present 
2 Mild Not more than 50% of cells are round; no extensive cell lysis and 
empty area between cells  
3 Moderate Not more than 70% of the cell layers contain rounded cells or are lysed 
4 Severe Nearly complete destruction of the cell layers 
 
Based on the results of this test it was determined that the experimental group did not incur 
any undue cytotoxic effects when compared to the results from the negative control. Because of this, 
we concluded that the methodology used to create our mold would also not induce cytotoxic effects 
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if it were used to produce a temporary spacer in the operating room, and thus, our device would be 
safe to use in this application.  
6.4 Cost Analysis  
  A cost analysis was performed to determine how our proposed device compares in cost to 
the existing Prostalac Hip System by DePuy. Table 13, which can be seen below, outlines a 
comparison of the cost of the different components that are necessary when performing a single 
procedure for a two-stage revision hip arthroplasty. Because UMMC performs about four of these 
procedures per year, we also provided a cost analysis projection of eight uses comparing our kit to 
the current gold standard; this can be seen below with the annual data expressed numerically in Table 
14, and graphically in Figure 29.  
Table 13: Cost Comparison of Prostalac Kit vs. Our Kit 
 
*Cost of stem, cup, and head provided by DePuy 
**Cost of standard hip stem, cup, and head stocked by hospital
67 
 
 
Table 14: Cost Comparison of the Prostalac Kit vs. Our system after Eight Uses 
Use 
Number  
Prostalac  Our 
System  
1 $6,036 $3,456  
2 $12,072 $6,912  
3 $18,108 $10,368  
4 $24,144 $13,824  
5 $30,180 $17,280  
6 $36,216 $20,736  
7 $42,252 $24,192  
8 $48,288 $27,648  
*Total Saved =$20,640 
 
Figure 29: Comparison of cumulative cost over time for the Prostalac kit and our system 
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Chapter 7: Discussion 
7.1 Validation of Met Constraints 
 To evaluate the success of our device we needed to ensure that our device was able to 
overcome all of the constraints that were initially presented to us. This was done by analyzing the 
results of the dimensional analysis, microscopy analysis, cytotoxicity testing, and cost analysis.  
7.1.1 Dimensional Analysis 
 The measurement values obtained for the original hip prosthesis and the PMMA component 
yielded a p-value greater than 0.05. This indicates that the numbers are not significantly different and 
that the newly formed component is comparable in size to the original implant.  
7.1.2 Microscopy Analysis 
 Visible deposits of PDMS on the device could not be distinguished, indicating that 
unwanted deposition of PDMS from our mold onto the component was not an issue that needed 
further consideration. 
7.1.3 Sterility & Cytotoxicity Testing 
 The percentage of live to dead cells in the negative control was found to not be statistically 
different from the percentage of live to dead cells in the experimental group. Both the negative 
control and the experimental group were found to have statistically significantly different 
percentages of live to dead cells. This indicates that we can assume our experimental group to not 
impart cytotoxic effects onto tissue when implanted into the body.  
7.1.4 Cost Analysis 
 Because the Prostalac Hip System requires a given expense that must be paid for each 
procedure when needed, the cost over time of this system increases in a linear fashion beginning 
with the first procedure. Our proposed system requires that a preliminary investment be put in to 
receive an initial, full set of molds, customized to the surgeons preferences; however, following this 
preliminary expense, which in and of itself still does not surpass the cost of a single use of the 
Prostalac Hip System, our device only requires that surgeons restock the single mold that is used 
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during a given procedure. The cost of a single mold is only $147 and with all necessary equipment 
our kit costs $3,456, whereas the Prostalac Hip System costs $6,036 for a single use. This means that 
while the initial cost of our system is comparable to a single use of the Prostalac Hip System, the 
annual cost over eight uses will be 43% less than that of the Prostalac Hip System, indicating that 
our proposed system is a cost effective alternative to the Prosalac Hip System. 
 Through this testing, we have proved that our method and device provide an efficacious, 
safe, and cost-effective alternative to be used to create the antibiotic-loaded bone cement spacer 
used in two-stage revision hip arthroplasties. These test results indicate that our method and device 
created for approaching this problem is successful in overcoming the pre-prescribed constraints of 
safety, efficacy, and cost effectiveness.  
7.2 Analysis of Met Objectives 
 Because our device was successful in overcoming all of our preliminary constraints, we 
looked to validate where our device was successful in meeting our objectives.  
7.2.1 Customizable 
 Through our dimensional analysis, we have proved that our method is efficacious in 
producing components that match the dimensions of an existing implant. We conclude that this 
method can be used with any brand or model of hip implant and the same results can be achieved. 
We thus believe we can say that success was achieved in creating a customizable system. 
 Additionally, we believe that because our device is entirely customizable, it will also be able 
to accommodate for the needs for the constantly changing marketplace for orthopedic implants. 
With new models of hip implants coming out each year, it is important that our technology is able to 
adapt to the ever-changing market. We believe our device achieves such, making it applicable and 
viable to perform this procedure for many years to come.  
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7.2.2 Accessible 
 Because there currently only exists a single Prostalac Hip System in all of New England that 
must be shared amongst the regional hospitals and because of the exorbitant cost of purchasing 
another system specifically for each hospital, the Prostalac Hip System is, overall, highly inaccessible. 
However, because our system is so cost-effective, each hospital can easily stock its own kit to have 
available for use whenever a septic revision surgery is necessitated. Surgeons can have the system 
available at all times and therefore do not have to wait to receive the device from an external vendor, 
while they additionally will not have to run into conflicts should the device be needed by two 
surgeons on the same day. Having our system available in stock in the hospital could therefore 
reduce the rate of co-morbidities associated with an infected implant.  
7.2.3 Disposable 
 Because our device was manufactured in such a way that it is resultantly so much more cost-
effective than existing methods, we propose that this can be used as a disposable device. This means 
that if the surgeon would like to simply cut the PDMS mold to dislodge the PMMA component 
after curing, they are free to do so because the mold will simply get discarded anyway following the 
surgery. This eliminates the need for sterilization; the surgeon may simply order a new mold to 
replace the one that was used during the procedure.  
7.3 Project Impact  
 It is important to take into account the impacts that a product will have on several factors 
including: economics, the environmental impact, societal influence, political ramifications, ethical 
concern, health and safety issues, manufacturability, and sustainability.  
7.3.1 Economics 
 The results of this project would suggest that the kit of customized molds would be 
economically advantageous to both hospitals and patients undergoing the surgery. By using our 
product, hospitals would save over $2,000 per surgery for the instrumentation used in a two-stage 
arthroplasty. Based on the calculated cost of renting the Prostalac kit vs. buying our kit, over $20,000 
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could be saved with just eight uses of our kit. Additionally, if the product is less expensive for the 
hospitals to purchase, the cost of the surgery may also decrease for the patient. Especially when 
considering the case where a patient has to wait to receive the kit for this procedure to be 
performed, the expense incurred by the increased time spent in the hospital would also decrease.    
7.3.2 Environmental Impact 
 Low molecular weight PDMS polymers are used in household care products, while high 
weight PDMS polymers are used as antifoams and lubricants. Also PDMS-based rubbers or sealants 
are used as textile coatings, electronics, silicone moldings and rubber gaskets. Since silicone and 
PDMS is used so commonly in everyday products, the customizable molds should have no greater 
negative effects on the natural environment than these current products. Solid silicones that enter 
the environment will be land filled or incinerated. Therefore, they are converted back to inorganic 
ingredients such as amorphous silica, carbon dioxide, and water vapor (Stevens, n.d.)  Since the 
material can be recycled and reused in other applications, the reuse reduces its environmental 
impact. 
7.3.3 Societal Influence 
Because there is just one kit in the New England region, if multiple hospitals need to 
perform a two-stage arthroplasty on the same date, one patient will suffer and endure further pain. 
Also, if an infection is detected when the surgeon believes there is a mechanical failure, the necessary 
components are not available on the shelf to perform the emergency surgery. Therefore, our 
product has a positive societal influence since patients can be treated right away and will not have to 
endure further physical and emotional pain while waiting for the kit. Our kit thus allows the overall 
quality of patient care to increase. 
7.3.4 Political Ramifications 
The main goal of our project was to create a more accessible way to conduct a two-stage 
revision arthroplasty. We hope our system can be used in the future to help surgeons and patients 
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accomplish these surgeries much faster, so there is less pain endured by the patient. This system will 
have an impact on the health care system but with relation to political ramifications, the impact is 
minimal.  
7.3.5 Ethical Concern 
Our project has minimal ethical concerns. However, one ethical concern could arise when 
considering that we would be scanning other companies’ hip stems. While we do not believe we are 
infringing on existing patents, if this were to be a concern, we could simply obtain the existing CAD 
files from these companies with their approval to create the mold, rather than scanning the hip 
stems obtained from a surgeon. 
7.3.6 Health and Safety Issue 
The main materials used in our design, PDMS and ABS plus, are both biocompatible 
materials that can be autoclaved to ensure the safest environment for our device. Our group 
performed a cytotoxicity test to help ensure that our device was non-toxic and will not cause a 
harmful response. However, all of testing was done on our proof of concept so going forward 
further testing must be done for a potential final design that surgeons will be using. Due to the 
testing we have already accomplished and the use of biocompatible materials, the health risks 
associated with this device is minimal.  
7.3.7 Manufacturability 
Regarding the manufacturability of our project, one could easily reproduce the temporary 
spacer by following the aforementioned protocol for utilizing our molding system to form the 
temporary spacer. So long as a rendering of the hip stem is rapid prototyped, then the temporary 
spacer could easily be reproduced simply by injecting the negative PDMS mold with antibiotic-
loaded PMMA bone cement, inserting the hip stem into the mold, and allowing the bone cement to 
cure. Since the surgeon would be provided PDMS molds for each size of hip stem that he regularly 
stocks on his shelves, he would only need to concern himself with forming the temporary spacer 
73 
 
and not the PDMS mold. That being said, the manufacturability of our project is dependent upon 
the ease with which the PDMS mold could be reproduced.  
7.3.8 Sustainability 
Since the PDMS molds are disposable, there is concern for how the disposal of the molds 
might affect the environment. As stated earlier, releases to the environment from the manufacturing 
of PDMS will either be landfilled or incinerated; in the case of incineration, PDMS degrades and is 
converted to inorganic constituents, amorphous silica, carbon dioxide, and water vapor. If the 
disposed PDMS is landfilled, there are no adverse effects because PDMS is too large to pass through 
the biological membranes of plants and animals (Stevens, n.d.). 
Also notable to mention regarding sustainability is that our methodology allows the devices 
used for this procedure to evolve and change with changing hip technologies. Even if the geometry 
of hip stems evolves over time, our system will not have to be modified to produce the necessary 
molds to fit the new implant technologies. In this sense, our methodology is sustainable for this 
application.  
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Chapter 8: Conclusions & Recommendations 
 In this study, we produced a medical device, which through cytotoxicity testing, we deem is 
safe to use for a two-stage hip revision arthroplasty. Through dimensional analysis, we were able to 
determine that our device can create a temporary PMMA component that is effectively the same size 
as the surgeons’ original permanent, metal hip implant. This means that our device can allow 
surgeons to utilize broaches and other equipment they already have in stock while still being able to 
produce an efficacious, temporary component. We determined through cost analysis that our device 
will allow surgeons to perform a two-stage revision arthroplasty procedure at a cost much less than 
that of the current Prostalac system. Because of the cost effectiveness of our device, it can be 
disposable, increasing ease-of-use for the surgeon because they do not need to worry about 
damaging the mold during the procedure. The low cost of the system furthermore makes the device 
highly accessible because all surgeons can stock this device for an affordable cost compared to 
existing technologies. 
 Additionally, our device is entirely customizable to surgeon needs and preferences. No 
matter what implant model a surgeon keeps regularly stocked, our system for creating molds allows 
for any model of hip implant to be accommodated for. As the technology continues to change and 
new models of implants continue to come out, our system for creating these molds will continue to 
be adaptable to accommodate for whatever geometry of hip implant needs to be accommodated for.  
 Regarding continued work to be done, we would like to create kits with full sets of molds 
corresponding to the broaches and hip stems that the surgeon prefers. Some work still needs to be 
done if we are to pursue 510K FDA approval for our device. To establish 510K approval for our 
medical device, we identified predicate devices to support our claims. However, other testing may 
still be necessary; we propose that a shelf-life test be performed on our device to determine how 
long a surgeon may keep a kit stocked before he or she may have to purchase new molds if they 
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have gone unused for too long. Also, we would like to manufacture a smaller container to make the 
mold as the amount of PDMS used could be reduced significantly with this modification. Lastly, we 
would like to expand our market by applying this methodology to both knee and shoulder infection 
surgeries as well.  For infected hip and knee revision surgeries alone, the market value could be 
expanded to $1.6 billion (Kurtz, 2007). Therefore, there is ample opportunity for our system to have 
a great influence in the medical device industry. 
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Appendix A:  
Dimensional Rendering Using Templates of Commonly used Hip Implants 
Utilizing surgical templates of hip stems from Stryker, Biomet, and Smith & Nephew, 
overlays, shown in Figure 30 could be drafted to determine the dimensions necessary to design a 
broach that could accommodate for the slight variations that exist between prostheses brands.  
 
 
Figure 30: Surgical template overlays used for determination of dimensions 
 We first overlaid the smallest and largest hip stems from each company and took 
photographs of the side and front views. To determine accurate dimensions from these overlays, 
measurements were taken, using ImageJ software, of the smallest size stems and the largest size 
stems, to determine what range of dimensions our broach would have to accommodate for.  
Once we were able to determine the upper and lower limits for the broach sizes, we 
developed intermediate sizes by creating a standard curve. Dimensional analysis of the prostheses 
used by UMMC could be converted to a SolidWorks model that would then be used to manufacture 
the broaches. The molds could then be modeled in SolidWorks with the same dimensions as the 
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broaches, but with a 0.5 mm. shell to be manufactured as well. The SolidWorks models for both the 
broaches and molds can be seen in Figure 31. 
   
Figure 31: 3-D SolidWorks model of initial broach and mold design 
Material Selection for Broaches and Molds 
It was necessary to determine a variety of material options to consider for the design of an 
effective broach and mold. For the broaches, we assembled a table of the relevant material 
properties including hardness, Young’s modulus, compressive strength, fracture toughness, and 
price of various polymers, including: ABS plastic, polycarbonate, ultra-high molecular weight 
polyethylene (UHMWPE), and nylon. Similarly, we tabulated the previously stated material 
properties of 316L stainless steel and aluminum to compare their properties to those of polymers. 
The mechanical properties of the polymers and metals were subsequently compared to those of 
cancellous bone to assess whether or not the broaches manufactured from these materials could cut 
through the cancellous bone of the femur, as is necessary when broaching the femoral canal. The 
material for the mold would ideally be non-adhesive and able to be cut away from the temporary 
component once the prosthesis had cured. We researched silicone for this purpose. Also for the 
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box, or outermost encasing of the mold, we would use an inexpensive polymer or metal. This table 
of values is shown in Table 15.  
Table 15: Material properties including price, hardness, elastic modulus, compressive strength, and fracture toughness 
 
Testing Various Polymers by Cutting through Wooden Dowels and Porcine Femurs 
Regarding the broach, preliminary testing was carried out to determine the feasibility of 
using a polymer versus a metal as the material chosen for the broach. To perform these tests, we 
acquired samples of a variety of materials including ultra-high molecular weight polyethylene 
(UHMWPE), polycarbonate, nylon, and ABS plastic, the specifications of which can be seen in Table 
15. These materials were chosen based on their mechanical properties and how they compared to 
those of cancellous bone.  
 We then acquired a fresh frozen bovine femur that had been sawed laterally, down the 
diaphysis of the bone to expose the medullary canal and cancellous bone. The yellow marrow plug 
of the bone was removed, and they were then thawed in a 0.9% saline solution for 90 minutes 
(Ipsen B. J. et al., 2003).  
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 We first tested the UHMWPE because teeth could be manually cut into the rods using a box 
cutter (Figure 32). Before testing the device on the bovine femur, preliminary tests were carried out 
on pine wooden dowels (Figure 33); based on hardness values, it appeared that UHMWPE would be 
able to cut through the dowel, as well as the cancellous bone. While the device was initially sharp to 
the touch, the teeth were found to dull within the first one to two sawing motions. While the 
recorded mechanical values for this material appeared as if they may be able to cut through the 
dowel and bone, it became clear that the teeth carved into the UHMWPE rod were unable to retain 
their structural integrity when subjected to the shear forces imparted by a sawing motion. We 
repeated the test on the bovine femur as well to be certain, and again came to the same conclusion 
that this material would not retain its structural integrity and would be incapable of clearing the 
femoral canal if made into a broach.  
 
Figure 32: Teeth cut into UHMWPE rod to test on wooded dowels and bovine femur for a proof of concept 
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Figure 33: Result of cutting wood with UHMWPE formed teeth 
 Similarly, tests were conducted on the ABS plastic that were carried out on UHMWPE. 
Initially, the ABS plastic was able to saw right through the wooden dowel as seen in Figure 34.  Next, 
we used the ABS plastic rod and attempted to saw through the bovine femur. The ABS plastic failed 
to cut the bone and the plastic teeth either chipped away or became dull after attempting to saw 
through the bone (Figure 35). From these results, we determined that ABS plastic would not retain its 
structural integrity and would be incapable of clearing the femoral canal if manufactured into a 
broach.  
 
Figure 34: ABS teeth and result of sawing wooden dowel with this instrument 
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Figure 35: Porcine femur cut with ABS teeth (negligible damage to cortical bone) 
Although the mechanical properties of these polymers were higher than that of cancellous 
bone, we did not consider that the surgeon would have to cut through some cortical bone during the 
surgery. Therefore, it is logical that the rods tested could not cut through the porcine femur. We 
determined that the mechanical properties of the polymers that we had chosen for the broaches are 
not sufficient enough for the purpose of effectively broaching the femoral canal. Of even greater 
concern was our discovery of the price it would cost to manufacture the broaches. We learned that 
our design would have to be outsourced to an external company to ensure the proper dimensions 
and details of our design. 
Manufacturing 
3-D Printed Broach  
Although we had doubts regarding manufacturing the broaches out of polymers, we decided 
to research various manufacturing techniques and the associated cost to do so. Having the broach 
design already in SolidWorks, our first thought was to research 3-D printing the set of broaches. 
Specifically, we researched printing the device in ABS plastic or nylon. However, the quote we 
received was $232 per broach for ABS plastic and $324 per broach for nylon. If we were to produce 
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a kit of at least five broaches, the kit itself would have been too expensive for it to be considered 
disposable. 
Injection Mold Broach  
 In this iteration of the design, we proposed fabricating a mold of a rendered broach for 
injection molding purposes. The broach mold could then be injected with our material of choice, 
allowed to cure, and peeled away from the shell, leaving behind a plastic broach component. 
Traditional injection molding projects, for which a metal mold is produced and then injected with 
the client's material of choice, usually cost over $2,000 for small, simple parts. If we were to pursue 
this more traditional option, the cost alone for producing five molds of different sizes would likely 
cost well over $10,000. 3-D printing our broach molds could significantly decrease that cost. The 
main drawback, however, to 3-D printing a broach mold, lies in the fact that 3-D printed injection 
molding systems are only meant for short injection molding runs of about 10 to 100 parts. Having 
to repeat the process of manufacturing these molds could then lead to even greater costs in the end. 
Due to these realizations, we determined this would not be a feasible option to pursue either. 
Due to the results from testing the costs associated with the manufacturing techniques our 
device would necessitate, we decided to look back to our other design alternatives of Universal and 
Customizable Molds.  
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Appendix B:  
 
Results from dimensional analysis for the temporary spacer (component) compared to the original 
hip stem provided to us by Doctor Wixted.  
Table 16: Dimensions obtained from measuring every cm along both the temporary spacer and original hip stem at the front, 
side, and back faces (mm) 
Front Face (mm)  Side Face (mm)  Back Face (mm) 
        
Original Component Original Component Original  Component 
9.66 9.87  9.52 9.69  9.57 9.86 
10.2 10.17  10.25 10.39  10.14 10.77 
10.97 11.36  10.85 10.98  10.71 11.48 
11.61 11.82  11.37 11.49  11.43 11.77 
12.21 12.36  11.81 11.59  12.02 12.46 
12.78 12.75  12.35 12.28  12.57 12.95 
13.34 13.11  12.94 12.67  13.06 13.34 
14.14 13.63  13.34 12.75  13.82 13.69 
14.45 13.82  13.62 13.17  14.28 13.89 
14.88 14.08  14.7 13.7  14.68 14.25 
15.26 14.35  16.15 14.92  14.92 14.37 
15.73 14.54  17.86 16.23  15.23 14.61 
16.28 15.34  20.72 17.95  15.67 15.38 
17.02 15.96  24.63 20.46  16.35 15.85 
18.1 17.12  29.55 24.44  17.33 17.33 
 
 
 
